IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

With budgets shrinking healthcare providers are under greater pressure than ever to deliver value, optimizing procedures and providing cost-and time-efficient care. Point-of-care testing can support this—equipping healthcare professionals with the information they need to make smart, on-the-spot medical decisions that improve workflow efficiency and, ultimately, patient outcomes.

As a leader in health technology, our goal at Philips is to revolutionize healthcare management. Where currently diagnostic blood testing is often carried out in a laboratory setting, we’re innovating to move beyond these walls and bring it near the patient—wherever they need it.

In 2016, we took our first step toward achieving this goal, launching the Minicare I-20 handheld system with cardiac troponin-l (cTnI) assay for suspected heart attack, delivering lab comparable results within just 10 minutes.

Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care

Now we have reached another important milestone with the launch of additional next generation Minicare in-vitro diagnostics systems:

• The Minicare C-300*—a clinical chemistry system that enables physicians to bypass the often time-consuming process of sending blood samples to a central or external laboratory for an extensive range of 27 chemistry parameters

• The Minicare H-300*—a hemostasis system that aids in the diagnosis and monitoring of coagulation abnormalities, giving the physicians crucial information in real time in critical care settings such as heavy blood trauma or massive surgery

• Minicare BNP*, an additional cardiac assay for the Minicare I-20, measuring the BNP (Brain Natriuretic Peptide) concentration in blood, to aid in the diagnosis of heart failure providing lab comparable test results within 10 minutes

By providing advanced clinical information through meaningful, cost-efficient and connected solutions, Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care.

With these advanced technologies and easy to use systems, Philips is helping to supply care providers with all the information they need to make decisions in the moments that matter, supporting them to streamline the patient journey and ensure that each individual gets the care they need.

Read Also

An Enhanced Approach to Patient Engagement

An Enhanced Approach to Patient Engagement

David Levine, Regional Medical Director, TeamHealth
Why Your Innovation Program Should be in Lock Step With Your Corporate Strategy

Why Your Innovation Program Should be in Lock Step With Your Corporate Strategy

Michael Schmidt, MBA, Managing Director, Orlando Health Strategic Innovations
Wearable Devices Offer Great Possibilities for Health Care

Wearable Devices Offer Great Possibilities for Health Care

Bhawna Jha, Interventional Pain Management Specialist, UAMS
The Possibilities of Patient Engagement

The Possibilities of Patient Engagement

Isaac Dapkins, MD, Chief Medical Officer of the Family Health Centers at NYU Langone
A Holistic Approach is the Key to Enterprise Patient Engagement Success

A Holistic Approach is the Key to Enterprise Patient Engagement Success

Geeta Nayyar, MD, MBA, Chief Health and Innovation Officer, Femwell Group Health
How to keep Communicating, Collaborating and Innovating as we Shift to a New Remote Working World

How to keep Communicating, Collaborating and Innovating as we Shift to a New Remote Working World

Whitney Sales, General Partner, Acceleprise Ventures and Olivia O’Sullivan, Director of Corporate Innovation and Partnerships, Acceleprise Ventures